☆ 4.7 Article

Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody

LAB ON A CHIP (2010)

Get Full Text
Add to Collection

Journal

LAB ON A CHIP
Volume 10, Issue 1, Pages 27-29

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/b917959c

Keywords

-

Categories

Biochemical Research Methods Chemistry, Multidisciplinary Chemistry, Analytical Nanoscience & Nanotechnology Instruments & Instrumentation

Funding

  1. National Science Foundation [ECS- 0335765]
  2. Cornell Nanobiotechnology Center
  3. Prostate Cancer Foundation Creativity Award
  4. New York State Foundation for Science, Technology, and Innovation
  5. NIH Clinical & Translational Science Center
  6. David H. Koch Foundation
  7. Robert H. McCooey Cancer Research Fund
  8. NATIONAL CANCER INSTITUTE [U54CA143876] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Geometrically enhanced differential immunocapture (GEDI) and an antibody for prostate-specific membrane antigen (PSMA) are used for high-efficiency and high-purity capture of prostate circulating tumor cells from peripheral whole blood samples of castrate-resistant prostate cancer patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.